Proton pump inhibitor therapy for peptic ulcer bleeding: Cochrane collaboration meta-analysis of randomized controlled trials

Mayo Clinic Proceedings

Volumn 82, Issue 3, 2007, Pages 286-296

  Leontiadis, Grigoris I ^a   Sharma, Virender K ^b   Howden, Colin W ^a,c  

^a DEMOCRITUS UNIVERSITY OF THRACE MEDICAL SCHOOL   (Greece)

^b MAYO CLINIC   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; ESOMEPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR;

ARTICLE; BLOOD TRANSFUSION; BOLUS INJECTION; CLINICAL TRIAL; COCHRANE LIBRARY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG INDICATION; DRUG MEGADOSE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL HEMORRHAGE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; MORTALITY; MULTICENTER STUDY; PEPTIC ULCER; PEPTIC ULCER BLEEDING; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

EID: 33847409654     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/82.3.286     Document Type: Article

References (42)

1. Leontiadis GI. McIntyre L, Sharma VK, Howden CW. Proton pump inhibitor treatment for acute peptic ulcer bleeding. Cochrane Database Syst Rev. 2004;(3):CD002094.
2. Leontiadis GI, Sharma VK, Howden CW. Systematic review and meta-analysis of proton pump inhibitor therapy in peptic ulcer bleeding. BMJ. 2005 Mar 12;330:568-570. Epub 2005 Jan 31.
3. Leontiadis GI, Sharma VK, Howden CW. Proton pump inhibitor treatment for acute peptic ulcer bleeding. Cochrane Database Syst Rev. 2006;(1):CD002094.
4. Higgins JPT, Green S. eds. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5. In: The Cochrane Library. Issue 3. Chichester. UK: John Wiley & Sons. Ltd: 2005.
5. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-634.
6. Desprez D, Blanc P, Bories JM, et al. Acute upper gastrointestinal hemorrhage: preliminary report of a randomized controlled trial comparing intravenous administration of ranitidine and omeprazole [abstract]. Gastroenterology. 1995;108(suppl):A82.
7. Fried R, Beglinger C, Meier R, et al. Comparison of intravenous pantoprazole with intravenous ranitidine in peptic ulcer bleeding [abstract]. Gut. 1999;45(suppl 5):A100. Abstract P0104.
8. Duvnjak M, Supanc V, Troskot B, et al. Comparison of intravenous pantoprazole with intravenous ranitidine in prevention of rebleeding from gastroduodenal ulcers [abstract]. Gut. 2001;49(suppl 3):abstract 2379.
9. Barkun A, Racz I, van Rensburg C, et al. Prevention of peptic ulcer rebleeding using continuous infusion of pantoparzole vs ranitidine: a multicenter, multinational, randomized, double-blind, parallel-group comparison [abstract]. Gastroenterology. 2004;126(suppl 2):A-78. Abstract 609.
10. Jensen DM, Pace SC, Soffer EF, Mack ME, Comer GM. Lower rebleeding rates in high risk patients treated with IV pantoprazole than IV ranitidine after endoscopic hemostasis in a randomised controlled US study [abstract]. Am J Gastroenterol. 2004;99(suppl):S296. Abstract 903.
11. Brunner G, Chang J. Intravenous therapy with high doses of ranitidine and omeprazole in critically ill patients with bleeding peptic ulcerations of the upper intestinal tract: an open randomized controlled study. Digestion. 1990;45:217-225.
12. Daneshmend TK, Hawkey CJ, Langman MJS, Logan RF, Long RG, Walt RP. Omeprazole versus placebo for acute upper gastrointestinal bleeding: randomised double blind controlled study. BMJ. 1992;304:143-147.
13. Michel P, Duhamel C, Bazin B, et al. Lansoprazole versus ranitidine dans la prévention des récidives précoces des hémorragies digestives ulcéreuses gastro-duodénales. Gastroenterol Clin Biol. 1994;18:1102-1105.
14. Pérez Flores R, García Molinero MJ, Herrero Quirós C, et al. Tratamiento de la hemorragia digestive alta de origen péptico: ranitidina intravenosa versus omeprazol intravenoso. Rev Esp Enferm Dig. 1994;86:637-641.
15. Lanas A, Artal A, Blas JM, Arroyo MT, Lopez-Zaborras J, Sainz R. Effect of parenteral omeprazole and ranitidine on gastric pH and the outcome of bleeding peptic ulcer. J Clin Gastroenterol. 1995;21:103-106.
16. Villanueva C, Balanzo J, Torras X, et al. Omeprazole versus ranitidine as adjunct therapy to endoscopic injection in actively bleeding ulcers: a prospective and randomized study. Endoscopy. 1995;27:308-312.
17. Cardi M, Muttillo IA, Amadori L, et al. Omeprazole versus ranitidine intraveineux dans le traitement de l'ulcere duodenal hemorragique: une etude randomisee prospective. Ann Chir. 1997;51:136-139.
18. Hasselgren G, Lind T, Lundell L, et al. Continuous intravenous infusion of omeprazole in elderly patients with peptic ulcer bleeding: results of a placebo-controlled multicenter study. Scand J Gastroenterol. 1997;32:328-333.
19. Khuroo MS, Yattoo GN, Javid G, et al. A comparison of omeprazole and placebo for bleeding peptic ulcer. N Engl J Med. 1997;336:1054-1058.
20. Labenz J, Peitz U, Leusing C, Tillenburg B, Blum AL, Borsch G. Efficacy of primed infusions with high dose ranitidine and omeprazole to maintain high intragastric pH in patients with peptic ulcer bleeding: a prospective randomised controlled study. Gut. 1997;40:36-41.
21. Lin HJ, Lo WC, Perng CL, Wang K, Lee FY. Can optimal acid suppression prevent rebleeding in peptic ulcer patients with a non-bleeding visible vessel: a preliminary report of a randomized comparative study. Hepatogastroenterology. 1997;44:1495-1499.
22. Schaffalitzky de Muckadell OB, Havelund T, Harling H, et al. Effect of omeprazole on the outcome of endoscopically treated bleeding peptic ulcers: randomized double-blind placebo-controlled multicentre study. Scand J Gastroenterol. 1997;32:320-327.
23. Coraggio F, Rotondano G, Marmo R, et al. Somatostatin in the prevention of recurrent bleeding after endoscopic haemostasis of peptic ulcer haemorrhage: a preliminary report. Eur J Gastroenterol Hepatol. 1998;10:673-676.
24. Lin HJ, Lo WC, Lee FY, Perng CL, Tseng GY. A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy. Arch Intern Med. 1998;158:54-58.
25. Lau JY, Sung JJ, Lee KK, et al. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med. 2000;343:310-316.
26. Javid G, Masoodi I, Zargar SA, et al. Omeprazole as adjuvant therapy to endoscopic combination injection sclerotherapy for treating bleeding peptic ulcer. Am J Med. 2001;111:280-284.
27. Sheu BS, Chi CH, Huang CC, Kao AW, Wang YL, Yang HB. Impact of intravenous omeprazole on Helicobacter pylori eradication by triple therapy in patients with peptic ulcer bleeding. Aliment Pharmacol Ther. 2002;16:137-143.
28. Kaviani MJ, Hashemi MR, Kazemifar AR, et al. Effect of oral omeprazole in reducing re-bleeding in bleeding peptic ulcers: a prospective, double-blind, randomized, clinical trial. Aliment Pharmacol Ther. 2003;17:211-216.
29. Xuan JL. Loseco compared with famotidine in the treatment of upper gastrointestinal bleeding: clinical analysis of 90 cases [in Chinese]. Guangxi Med J. 2003;25:529-531.
30. Leontiadis GI, Sharma VK, Howden CW. Systematic review and meta-analysis: enhanced efficacy of proton-pump inhibitor therapy for peptic ulcer bleeding in Asia-a post hoc analysis from the Cochrane Collaboration. Aliment Pharmacol Ther. 2005;21:1055-1061.
31. Leontiadis GI, Sharma VK, Howden CW. Systematic review and meta-analysis: proton-pump inhibitor treatment for ulcer bleeding reduces transfusion requirements and hospital stay-results from the Cochrane Collaboration. Aliment Pharmacol Ther. 2005;22:169-174.
32. Green FW Jr, Kaplan MM, Curtis LE, Levine PH. Effects of acid and pepsin on blood coagulation and platelet aggregation: a possible contributor to prolonged gastroduodenal mucosal hemorrhage. Gastroenterology. 1978;74:38-43.
33. Khuroo MS, Khuroo MS, Farahat KL, Kagevi IE. Treatment with proton pump inhibitors in acute non-variceal upper gastrointestinal bleeding: a meta-analysis. J Gastroenterol Hepatol. 2005;20:11-25.
34. Andriulli A, Annese V, Caruso N, et al. Proton-pump inhibitors and outcome of endoscopic hemostasis in bleeding peptic ulcers: a series of meta-analyses. Am J Gastroenterol. 2005;100:207-219.
35. Bardou M, Toubouti Y, Benhaberou-Brun D, Rahme E, Barkun AN. Meta-analysis: proton-pump inhibition in high-risk patients with acute peptic ulcer bleeding. Aliment Pharmacol Ther. 2005;21:677-686.
36. Barkun AN, Bardou M, Marshall JK, Nonvariceal Upper GI Bleeding Consensus Conference Group. Consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med. 2003;139:843-857.
37. 2 antagonists in acute upper gastrointestinal hemorrhage: implications of randomized trials. N Engl J Med. 1985;313:660-666.
38. 2-receptor antagonists in bleeding peptic ulcer. Aliment Pharmacol Ther. 2002;16:1137-1142.
39. Hsu PI, Lo GH, Lo CC, et al. Intravenous pantoprazole versus ranitidine for prevention of rebleeding after endoscopic hemostasis of bleeding peptic ulcers. World J Gastroenterol. 2004;10:3666-3669.
40. Khoshbaten M, Fattahi E, Naderi N, Khaleghian, Rezailashkajani M. A comparison of oral omeprazole and intravenous cimetidine in reducing complications of duodenal peptic ulcer. BMC Gastroenterol. 2006;6:2.
41. Lin HJ, Lo WC, Cheng YC, Perng CL. Role of intravenous omeprazole in patients with high-risk peptic ulcer bleeding after successful endoscopic epinephrine injection: a prospective randomized comparative trial. Am J Gastroenterol. 2006;101:500-505.
42. Zargar SA, Javid G, Khan BA, et al. Pantoprazole infusion as adjuvant therapy to endoscopic treatment in patients with peptic ulcer bleeding: prospective randomized controlled trial. J Gastroenterol Hepatol. 2006;21:716-721.